BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24297868)

  • 1. Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.
    Damm-Welk C; Mussolin L; Zimmermann M; Pillon M; Klapper W; Oschlies I; d'Amore ES; Reiter A; Woessmann W; Rosolen A
    Blood; 2014 Jan; 123(3):334-7. PubMed ID: 24297868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should treatment of ALK-positive anaplastic large cell lymphoma be stratified according to minimal residual disease?
    Rigaud C; Abbas R; Grand D; Minard-Colin V; Aladjidi N; Buchbinder N; Garnier N; Plat G; Couec ML; Duplan M; Lambilliotte A; Schmitt C; Leblanc T; Lamant L; Brugières L
    Pediatr Blood Cancer; 2021 Jun; 68(6):e28982. PubMed ID: 33687135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.
    Mussolin L; Damm-Welk C; Pillon M; Zimmermann M; Franceschetto G; Pulford K; Reiter A; Rosolen A; Woessmann W
    Leukemia; 2013 Feb; 27(2):416-22. PubMed ID: 22907048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.
    Iijima-Yamashita Y; Mori T; Nakazawa A; Fukano R; Takimoto T; Tsurusawa M; Kobayashi R; Horibe K
    Int J Hematol; 2018 Feb; 107(2):244-250. PubMed ID: 29030834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.
    Damm-Welk C; Pillon M; Woessmann W; Mussolin L
    Front Biosci (Schol Ed); 2015 Jun; 7(2):205-16. PubMed ID: 25961696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative PCR detection of NPM/ALK fusion gene and CD30 gene expression in patients with anaplastic large cell lymphoma--residual disease monitoring and a correlation with the disease status.
    Kalinova M; Krskova L; Brizova H; Kabickova E; Kepak T; Kodet R
    Leuk Res; 2008 Jan; 32(1):25-32. PubMed ID: 17320171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for
    Damm-Welk C; Kutscher N; Zimmermann M; Attarbaschi A; Schieferstein J; Knörr F; Oschlies I; Klapper W; Woessmann W
    Haematologica; 2020 Aug; 105(8):2141-2149. PubMed ID: 31649129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
    Eyre TA; Khan D; Hall GW; Collins GP
    Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
    Werner MT; Zhao C; Zhang Q; Wasik MA
    Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
    Damm-Welk C; Schieferstein J; Schwalm S; Reiter A; Woessmann W
    Br J Haematol; 2007 Aug; 138(4):459-66. PubMed ID: 17608768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
    Ladanyi M; Cavalchire G
    Diagn Mol Pathol; 1996 Sep; 5(3):154-8. PubMed ID: 8866227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
    Damm-Welk C; Lovisa F; Contarini G; Lüdersen J; Carraro E; Knörr F; Förster J; Zimmermann M; Sala A; Vinti L; Tondo A; Pillon M; Woessmann W; Mussolin L
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Relapsed Stage III Childhood Anaplastic Large Cell Lymphoma Patients with NPM-ALK Fusion in Bone Marrow from Initial Diagnosis.
    Kanazawa Y; Yamashita Y; Fujiwara M; Muraoka M; Washio K; Kanamitsu K; Ishida H; Nakano T; Yamada M; Horibe K; Tanaka T; Yoshino T; Shimada A
    Acta Med Okayama; 2016 Dec; 70(6):503-506. PubMed ID: 28003677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.
    Maes B; Vanhentenrijk V; Wlodarska I; Cools J; Peeters B; Marynen P; de Wolf-Peeters C
    Am J Pathol; 2001 Jun; 158(6):2185-93. PubMed ID: 11395396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The t(2;5) in human lymphomas.
    Kadin ME; Morris SW
    Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of the NPM-ALK fusion gene in bone marrow and peripheral blood for patients with anaplastic large cell lymphoma].
    Yang J; Zhao XX; Jin L; Duan YL; Huang S; Zhang M; Zhang R; Zhou CJ; Zhang YH
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):700-3. PubMed ID: 23978023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
    Ait-Tahar K; Damm-Welk C; Burkhardt B; Zimmermann M; Klapper W; Reiter A; Pulford K; Woessmann W
    Blood; 2010 Apr; 115(16):3314-9. PubMed ID: 20185586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
    Rigaud C; Knörr F; Brugières L; Woessmann W
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101444. PubMed ID: 36907641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
    Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.